Vyriad announces strategic collaboration with Novartis to develop in vivo CAR-T cell therapies
| PFPWX Fund | USD 60.07 0.17 0.28% |
Slightly above 54% of Parnassus Endeavor's investor base is interested to short. The analysis of overall sentiment of trading Parnassus Endeavor Fund mutual fund suggests that many investors are impartial at this time. Parnassus Endeavor's investing sentiment can be driven by a variety of factors including economic data, Parnassus Endeavor's earnings reports, geopolitical events, and overall market trends.
Parnassus |
Vyriad, Inc., a clinical-stage biotechnology company developing the next generation of targeted genetic therapies, today announced a strategic collaboration with Novartis to discover and develop in vivo chimeric antigen receptor T-cell therapies.
Read at finance.yahoo.com
 |
Parnassus Endeavor Fundamental Analysis
We analyze Parnassus Endeavor's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Parnassus Endeavor using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Parnassus Endeavor based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Parnassus Endeavor is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Parnassus Endeavor Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Parnassus Endeavor mutual fund to make a market-neutral strategy. Peer analysis of Parnassus Endeavor could also be used in its relative valuation, which is a method of valuing Parnassus Endeavor by comparing valuation metrics with similar companies.
Peers
Parnassus Endeavor Related Equities
| PRILX | Parnassus Equity | 0.45 | ||||
| PARWX | Parnassus Endeavor | 0.28 | ||||
| PARNX | Parnassus Fund | 0.25 | ||||
| PFPRX | Parnassus Fund | 0.24 | ||||
| PFPMX | Parnassus Mid | 0.22 |
Other Information on Investing in Parnassus Mutual Fund
Parnassus Endeavor financial ratios help investors to determine whether Parnassus Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Parnassus with respect to the benefits of owning Parnassus Endeavor security.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |